Torts/Personal Injury,
Class Action,
Civil Litigation
May 20, 2024
McKinsey to face claims over opioid related birth defects
The company has resolved most plaintiff groups' claims that the firm colluded with its clients to increase opioid addiction across the nation.
After settling with school districts and governmental entities earlier this year, McKinsey & Co. must face pared-down claims by children with birth defects and developmental disabilities for the consulting firm's alleged role in the national opioid crisis.
"We appreciate the court's thorough and thoughtful decision recognizing negligence-derived claims of neonatal abstinence syndrome newborns and children injured through opiate exposure, and the opportunity to mo...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In